|
WO0051638A1
|
|
Photodynamic therapy in combination with apoptosis inducing factors
|
|
US6096776A
|
|
Green porphyrins as immunomodulators
|
|
US6107325A
|
|
Green porphyrins as immunomodulators
|
|
AU7422098A
|
|
Green porphyrins as immunomodulators
|
|
WO9850387A1
|
|
Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
|
|
AU5777298A
|
|
Compositions and articles for reducing the effects of inflammation
|
|
CZ204799A3
|
|
Use of green porphyrins for preparing a medicament for treating after-cataract
|
|
CN1225566A
|
|
Improved phototherapeutic methods and devices for irradiating columnar environments
|
|
CA2248802A1
|
|
Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
|
|
US6043237A
|
|
Use of photodynamic therapy for prevention of secondary cataracts
|
|
US5882328A
|
|
Method to prevent transplant rejection
|
|
US5834503A
|
|
Methods to treat arterial plaque
|
|
US5756541A
|
|
Vision through photodynamic therapy of the eye
|
|
US5883246A
|
|
Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
|
|
US5707608A
|
|
Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
|
